654
Views
39
CrossRef citations to date
0
Altmetric
Original Article

D-Tagatose increases butyrate production by the colonic microbiota in healthy men and women

, &
Pages 47-57 | Received 14 Jul 2004, Accepted 25 Feb 2005, Published online: 11 Jul 2009

References

  • Levin GV, Zehner LR, Saunders JP, Beadle JR. Sugar substitutes: their energy values, bulk characteristics, and potential health benefits. Am J Clin Nutr. 1995;62:11615-8S.
  • Laerke HN, Jensen BB. D-tagatose has low small intestinal digestibility but high large intestinal fermentability in pigs. J Nutr. 1999;129:1002–9.
  • Normen L, Laerke HN, Jensen BB, Langkilde AM, Anders-son H. Small-bowel absorption of D-tagatose and related effects on carbohydrate digestibility: an ileostomy study. Am J Clin Nutr. 2001;73:105–10.
  • Bertelsen H, Andersen H, Tvede M. Fermentation of D-tagatose by human intestinal bacteria and dairy lactic acid bacteria. Microb Ecol Health Dis. 2000;13:87–95.
  • Laerke HN, Jensen BB, Hojsgaard S. In vitro fermentation pattern of D-tagatose is affected by adaptation of the microbiota from the gastro-intestinal tract of pigs. J Nutr. 2000;130:1772–9.
  • Young GP, Gibson RP. Butyrate and the colorectal cancer cell. In: Binder HJ, Cummings J, Soergel KH. editors. Short chain fatty acids. Dordrecht: Kluwer Academic; 1995. p. 148–60.
  • Scheppach W, Bartram HP, Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer. 1995;31:1077–80.
  • Minekus M, Smeets-Peeters MJE, Bernalier A, Marol-Bonnin S, Havenaar R, Marteau P, et al. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fer-mentation products. Appl Microb Biotechnol. 1999;53:108–14.
  • Venema K, Van Nuenen HMC, Smeets-Peeters MJE, Mine-kus M, Havenaar R. TNO's in vitro large intestinal model: an excellent screening tool for functional food and pharmaceu-tical research. Ernährung/Nutrition. 2000;24:558–64.
  • Declaration of Helsinki. Republic of South Africa: Somerset West, 1996.
  • ICH Guidelines for Good Clinical Practice. ICH Topic E6, adopted 01-05-1996 and implemented 17-01–1997.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Chin Chem. 1972;18:499–502.
  • Hartemink R, Domenech VR, Robouts FM. LAMVAB - a new selective medium for the isolation of lactobacilli from faeces. J Microbiol Methods. 1997;29:77–84.
  • Venema K, Van Nuenen HMC, Van den Heuvel EG, Pool W, Van der Vossen JMBM. The effect of lactulose on the composition of the intestinal microbiota and short chain fatty acid production in human volunteers and a computer-controlled model of the proximal large intestine. Microb Ecol Health Dis. 2003;15:94–105.
  • Jensen BB, Jorgensen H. Effect of dietary fiber on microbial activity and microbial gas production in various regions of the GI tract of pigs. Appl Environ Microbiol. 1994;60:1897–904.
  • Zoetendal EG, Akkermans ADL, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific commu-nities of active bacteria. Appl Environ Microbiol. 1998;64:3854–9.
  • Harmsen HJ, Gibson GR, Elfferich P, Raangs GC, Wild-eboer-Veloo AC, Argaiz A, et al. Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett. 2000;183:125–9.
  • Jouany JP. Volatile fatty acids and alcohols determination in digestive contents, sillage juice, bacterial culture, and anae-robic fermented contents. Sci Aliments. 1982;2:131–44.
  • Van Nuenen HMC, Meyer PD, Venema K. The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microb Ecol Health Dis. 2003;15:137–44.
  • Gibson GR, Cummings JH, Macfarlane GT. Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol. 1988;54:2750–5.
  • Statistical Analysis System. SAS System for Windows. Re-lease 8.02 TS level 02M0. Cary, NC: Sas Institute Inc., 1999-2001.
  • Bertelsen H, Jensen BB, Buemann B. D-tagatose. A novel low-calorie bulk sweetener with prebiotic properties. World Rev Nutr Diet. 1999;85:98–109.
  • Gibson GR, Beatty ER, Wang X, Cummings JR. Selective stimulation of bifidobacteria in the human colon by oligo-fructose and inulin. Gastroenterology. 1995;108:975–82.
  • Van Loo J, Cummings J, Delzenne N, Englyst H, Franck A, Hopkins M, et al. Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr. 1999;81:121–32.
  • Rao AV. Dose-response effects of inulin and oligofructose on intestinal bifidogenic effects. J Nutr. 1999;129:14425–55.
  • Roberfroid MB. Chicory fructooligosaccharides and the gastrointestinal tract. Nutrition. 2000;16:677–9.
  • Klaenhammer TR. Functional activities of lactobacillus probiotics: genetic mandate. hit Dairy J. 1998;8:497–505.